Actively Recruiting
Risk Assessment for HBV-Related Liver Cancer
Led by Sun Yat-sen University · Updated on 2025-09-08
6000
Participants Needed
1
Research Sites
398 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Liver cancer is a severe disease worldwide. The incidence and mortality rates of liver cancer in China is the highest in the world. This project aims to perform a prospective, multi-center, large sample cohort study for HBV related high-risk individuals. Based on multimodal data fusion and AI technique, stratified management and follow-up system are conducted for HBV-related high-risk populations of liver cancer, in order to improve the early diagnosis rate of liver cancer.
CONDITIONS
Official Title
Risk Assessment for HBV-Related Liver Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Positive for Hepatitis B surface antigen
- Age between 30 and 75 years
- Must meet one or more of the following: ultrasound/CT/MRI shows liver cirrhosis; type II diabetes; family history of liver cirrhosis or liver cancer; long-term alcohol consumption over 5 years with at least 40g/day for males or 20g/day for females; liver histology Metavir fibrosis score F3 or above; Fibroscan value (LSM) 8.0kPa or higher
You will not qualify if you...
- Diagnosed with malignant tumors
- Have had a liver transplant
- Infected with HIV
- Expected survival time less than 1 year
- Have severe organ dysfunction (heart, brain, kidney, lung, endocrine system, blood, etc.) or psychiatric disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510630
Actively Recruiting
Research Team
B
Bingliang Prof. Lin
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here